Clinical burden of autosomal dominant polycystic kidney disease

doi:10.18632/aging.102858

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 生活保健科技系 > 期刊論文 > Item 310902800/34107

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34107

標題:	Clinical burden of autosomal dominant polycystic kidney disease
作者:	Hung, Peir-Haur Lin, Chien-Hung Hung, Kuan-Yu Muo, Chih-Hsin Chung, Mu-Chi Chang, Chao-Hsiang Chung, Chi-Jung
貢獻者:	Ditmanson Med Fdn, Dept Internal Med, Chiayi Christian Hosp Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth Taipei Vet Gen Hosp, Dept Pediat, Div Pediat Immunol & Nephrol Natl Yang Ming Univ, Inst Clin Med Taipei City Hosp, Dept Pediat, Zhongxing Branch Fu Jen Catholic Univ, Coll Sci & Engn Natl Taiwan Univ Hosp, Dept Internal Med China Med Univ Hosp, Management Off Hlth Data Taichung Vet Gen Hosp, Dept Med, Div Nephrol China Med Univ Hosp, Dept Urol China Med Univ Hosp, Dept Med Res China Med Univ, Dept Publ Hlth
關鍵字:	autosomal dominant polycystic kidney disease hemorrhagic stroke end-stage renal disease all-cause mortality time-dependent Cox proportional hazard regression
日期:	2020
上傳時間:	2022-11-18 11:24:12 (UTC+8)
出版者:	Impact Journals Llc
摘要:	There are no specific therapies for autosomal dominant polycystic kidney disease (ADPKD), and clinical data evaluating the effects of non-specific therapies on ADPKD patients are scarce. We therefore evaluated those effects using data from a longitudinal health insurance database collected from 2000-2010. We individually selected patients with and without ADPKD from inpatient data files as well as from the catastrophic illness registry in Taiwan based on 1:5 frequency matching for sex, age, and index year. The hazard ratios (HR) of all-cause mortality, ischemic stroke, hemorrhagic stroke and end-stage renal disease (ESRD) in ADPKD inpatients were elevated as compared to the controls. Similarly, ADPKD patients from the catastrophic illness registry had an increased risk of hemorrhagic stroke and ESRD. Allopurinol users also had an increased risk of all-cause mortality. The HR for developing ESRD after medication exposure was 0.47-fold for statin and 1.93-fold for pentoxifylline. These results reveal that patients with ADPKD (either inpatient or from the catastrophic illness registry) are at elevated risk for hemorrhagic stroke and ESRD, and suggest that allopurinol and pentoxifylline should not be prescribed to ADPKD patients due to possible adverse effects.
關聯:	Aging-Us, v.12, n.4, pp.12
显示于类别:	[生活保健科技系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	563	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....